GEMINI - THE IN SILICO PATIENT Trademark
Trademark Overview
On Monday, February 1, 2021, a trademark application was filed for GEMINI - THE IN SILICO PATIENT with the United States Patent and Trademark Office. The USPTO has given the GEMINI - THE IN SILICO PATIENT trademark a serial number of 90501338. The federal status of this trademark filing is REGISTERED as of Tuesday, December 21, 2021. This trademark is owned by GNS Healthcare, Inc.. The GEMINI - THE IN SILICO PATIENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Providing temporary use of non-downloadable cloud-based software for simulating and modeling an in silico patient; providing computer modeling services, namely, in silico modeling of disease progression and drug response in the fields of oncology, immunology, neurodegeneration, and cardiometabolic disease; consulting services for others in the field of computer modeling of blood cancer progression and solid tumor progression for use in clinical trial design and pharmaceutical drug development
General Information
| Serial Number | 90501338 |
| Word Mark | GEMINI - THE IN SILICO PATIENT |
| Filing Date | Monday, February 1, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 21, 2021 |
| Registration Number | 6594890 |
| Registration Date | Tuesday, December 21, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 5, 2021 |
Trademark Statements
| Disclaimer with Predetermined Text | "THE IN SILICO PATIENT" |
| Goods and Services | Providing temporary use of non-downloadable cloud-based software for simulating and modeling an in silico patient; providing computer modeling services, namely, in silico modeling of disease progression and drug response in the fields of oncology, immunology, neurodegeneration, and cardiometabolic disease; consulting services for others in the field of computer modeling of blood cancer progression and solid tumor progression for use in clinical trial design and pharmaceutical drug development |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 4, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, June 25, 2020 |
| First Use In Commerce Date | Thursday, June 25, 2020 |
Trademark Owner History
| Party Name | GNS Healthcare, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 |
| Party Name | GNS Healthcare, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 |
| Party Name | GNS Healthcare, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Somerville, MA 02143 |
Trademark Events
| Event Date | Event Description |
| Tuesday, December 21, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 5, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 5, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 15, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 31, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 31, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 31, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 31, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 31, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 23, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, May 4, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, February 4, 2021 | NEW APPLICATION ENTERED IN TRAM |
